Reuters logo
BRIEF-Tetra Bio-Pharma Receives Approval From Health Canada Of Its Phase 1 Clinical Trial With PPP005 (Cannabis Oil)
January 16, 2018 / 1:09 PM / 3 months ago

BRIEF-Tetra Bio-Pharma Receives Approval From Health Canada Of Its Phase 1 Clinical Trial With PPP005 (Cannabis Oil)

Jan 16 (Reuters) - Tetra Bio Pharma Inc:

* TETRA BIO-PHARMA RECEIVES APPROVAL FROM HEALTH CANADA OF ITS PHASE 1 CLINICAL TRIAL WITH PPP005 (CANNABIS OIL)

* TETRA BIO PHARMA - RECEIVED NO OBJECTION LETTER FROM THERAPEUTIC PRODUCTS DIRECTORATE HEALTH CANADA OF ITS PHASE 1 CLINICAL TRIAL WITH PPP005 (CANNABIS OIL) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below